tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA

Compare Palvella Therapeutics (PVLA) vs. Competitors

779 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Palvella Therapeutics
$127.12
$1.86B
-28.23
539.76%
13 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$16.55
$841.91M
8.89
94.87%
3 Buy
3 Hold
0 Sell
Moderate Buy
Monopar Therapeutics Inc
$57.92
$375.30M
-35.28
75.96%
7 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$16.24
$1.66B
-5.04
81.95%
11 Buy
0 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$52.56
$6.07B
-39.12
2359.35%
0 Buy
9 Hold
0 Sell
Hold
Tyra Bioscience
$36.69
$1.98B
-13.06
367.02%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PVLA
Palvella Therapeutics
127.12
102.68
420.13%
TBPH
Theravance Biopharma
16.35
7.62
87.29%
MNPR
Monopar Therapeutics Inc
56.08
18.59
49.59%
NRIX
Nurix Therapeutics
16.03
6.18
62.74%
TERN
Terns Pharmaceuticals
52.63
50.32
2178.35%
TYRA
Tyra Bioscience
35.26
26.83
318.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts